Cargando…

Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer

PURPOSE: There have been very few reports of secondary malignancies after breast cancer treatment in Asia, particularly in Japan. This study aimed to evaluate the risk of secondary malignancies after radiotherapy (RT) in Japanese breast cancer patients. METHODS: This single-center retrospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okonogi, Noriyuki, Karasawa, Kumiko, Nitta, Yuki, Mori, Yasumasa, Murata, Kazutoshi, Wakatsuki, Masaru, Tsuji, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287211/ https://www.ncbi.nlm.nih.gov/pubmed/35781767 http://dx.doi.org/10.1007/s10549-022-06644-x

Ejemplares similares

Secondary cancers after carbon‐ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study
por: Nitta, Yuki, et al.
Publicado: (2022)

Long-Term Outcomes of Carbon-Ion Radiotherapy for Malignant Gynecological Melanoma
por: Murata, Hiroto, et al.
Publicado: (2019)

Clinical advantage and outcomes of computed tomography‐based transvaginal hybrid brachytherapy performed only by sedation without general or saddle block anesthesia
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

Significance of concurrent use of weekly cisplatin in carbon‐ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score‐matched analysis
por: Okonogi, Noriyuki, et al.
Publicado: (2019)

A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy
por: Karasawa, Kumiko, et al.
Publicado: (2020)

Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion
por: Shiba, Shintaro, et al.
Publicado: (2016)

Carbon-ion radiotherapy for inoperable endometrial carcinoma
por: Irie, Daisuke, et al.
Publicado: (2018)

Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix
por: Okonogi, Noriyuki, et al.
Publicado: (2021)

Comparison of passive and scanning irradiation methods for carbon-ion radiotherapy for breast cancer
por: Matsubara, Hiroaki, et al.
Publicado: (2018)

Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001)
por: Okonogi, Noriyuki, et al.
Publicado: (2018)

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
por: Iwamoto, Takayuki, et al.
Publicado: (2016)

Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study
por: Otani, Yuki, et al.
Publicado: (2021)

Clinical trial of carbon ion radiotherapy for gynecological melanoma
por: Karasawa, Kumiko, et al.
Publicado: (2014)

Results of a nationwide survey on Japanese clinical practice in breast-conserving radiotherapy for breast cancer
por: Aibe, Norihiro, et al.
Publicado: (2019)

Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
por: Jacobs, D. H. M., et al.
Publicado: (2018)

Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023)

Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis
por: Okonogi, Noriyuki, et al.
Publicado: (2018)

Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens
por: Jacobs, Daphne H. M., et al.
Publicado: (2021)

Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer
por: Kang, Yu‐Mei, et al.
Publicado: (2022)

Cardiac impacts of postoperative radiotherapy for breast cancer in Japanese patients
por: Segawa, Erika, et al.
Publicado: (2023)

PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Barcellini, Amelia, et al.
Publicado: (2021)

A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer
por: Murata, Takeshi, et al.
Publicado: (2023)

Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)
por: Iwatani, Tsuguo, et al.
Publicado: (2021)

Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance
por: Inoue, Kenichi, et al.
Publicado: (2016)

The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
por: Collarino, Angela, et al.
Publicado: (2018)

Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results
por: Okonogi, Noriyuki, et al.
Publicado: (2023)

Comprehensive analysis of Japanese nationwide cohort data of particle beam therapy for pulmonary, liver and lymph node oligometastases: particle beam therapy versus high-precision X-ray radiotherapy
por: Aibe, Norihiro, et al.
Publicado: (2023)

Correction: Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
por: Schlich-Bakker, Kathryn J., et al.
Publicado: (2007)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

In-room computed tomography–based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study
por: Ohno, Tatsuya, et al.
Publicado: (2017)

Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life
por: Wyld, Lynda, et al.
Publicado: (2021)

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2014)

Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands
por: Walstra, Coco J. E. F., et al.
Publicado: (2021)

A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer
por: Iwata, Hiroji, et al.
Publicado: (2013)

The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study
por: Takahashi, Masato, et al.
Publicado: (2020)

Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance
por: Sanderink, W. B. G., et al.
Publicado: (2020)

Prognostic impact of breast cancer subtypes in elderly patients
por: Bergen, E. S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6h6he631b4c5pmdhadr56tn6nm